Dose‐adjusted EPOCH‐R is not superior to sequential R‐CHOP/R‐ICE as a frontline treatment for newly diagnosed primary mediastinal B‐cell lymphoma: Results of a bi‐center retrospective study-Reference-Cited by-同舟云学术

Dose‐adjusted EPOCH‐R is not superior to sequential R‐CHOP/R‐ICE as a frontline treatment for newly diagnosed primary mediastinal B‐cell lymphoma: Results of a bi‐center retrospective study

Published:2021-11-24 Issue:24 Volume:10 Page:8866-8875
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Morgenstern Yael¹,Aumann Shlomzion²,Goldschmidt Neta²,Gatt Moshe E.²,Nachmias Boaz²^ORCID,Horowitz Netanel A.¹³^ORCID

Affiliation:

1. Department of Hematology and Bone Marrow Transplantation Rambam Health Care Campus Haifa Israel

2. Department of Hematology Hadassah Medical Center and Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel

3. The Ruth and Bruce Rappaport Faculty of Medicine Technion – Israel Institute of Technology Haifa Israel

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4387

Reference29 articles.

1. Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

2. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

3. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

4. Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions

5. Characterization of DLBCL with a PMBL gene expression signature

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Результаты терапии первичной медиастинальной В-крупноклеточной лимфомы. Опыт МРНЦ им. А.Ф. Цыба (Обнинск);Clinical Oncohematology;2024-07-01

2. Updates in the Management of Primary Mediastinal B Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2023-12

3. Improved survival for dose-intensive chemotherapy in primary mediastinal B-cell lymphoma: a systematic review and meta-analysis of 4068 patients;Haematologica;2023-08-31

4. Outcome of Primary Mediastinal Large B Cell Lymphoma Treated with RCHOP;Journal of Blood Medicine;2023-02

5. Multiple drugs;Reactions Weekly;2022-09-24